Últimos ensayos

EudraCT Number: 2014-004897-40

Sponsor Protocol Number: GABA-2

Start Date:

Sponsor Name: PHARM – Pharmaceutical Research Management srl

Full Title: Randomized, double-blind, placebo controlled, multi-centre, superiority phase II study to evaluate the safety, pharmacokinetic, efficacy of gabapentin liquid formulation as add-on to morphine in ch...

Medical condition: Chronic pain of neuropathic or mixed origin

Disease:	Version	SOC Term	Classification Code	Term	Level
	19.1	100000004852	10054095	Neuropathic pain	LLT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Prematurely Ended) FR (Ongoing) NL (Prematurely Ended) IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2021-002339-44

Sponsor Protocol Number: IGM-2323-001

Start Date:

Sponsor Name: IGM Biosciences, Inc.

Full Title: A Phase 1/2 Open-Label, Multicenter Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of IGM-2323 in Subjects with Relapsed/Refractory Non-Hodgkin Lymphomas

Medical condition: Relapsed/Refractory (R/R) Non-Hodgkin lymphomas (NHL)

Disease:	Version	SOC Term	Classification Code	Term	Level
	23.0	100000004864	10025311	Lymphoma (non-Hodgkin's)	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed) ES (Ongoing) IT (Ongoing) DK (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2010-018781-23

Sponsor Protocol Number: 2917800009

Start Date:

Sponsor Name: Top Institute Food and Nutrition

Full Title: Diagnose of GH-deficiency: comparing the dietary-protein test with conventional Growth Hormone Stimulation Tests

Medical condition: To investigate if there is a correlation between the peak GH concentrations after ingestion of gelatin protein and the peak GH concentrations after the two standard tests (GHST) in order to discrim...

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.1		10056438	Growth hormone deficiency	LLT

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2015-003509-41

Sponsor Protocol Number: GBG90

Start Date:

Sponsor Name: GBG Forschungs GmbH

Full Title: A randomized phase II trial to assess the efficacy of paclitaxel and olaparib in comparison to paclitaxel / carboplatin followed by epirubicin/cyclophosphamide as neoadjuvant chemotherapy in patien...

Medical condition: Patients with triple negative or HRpositive, early breast cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10006187	Breast cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2015-002882-41

Sponsor Protocol Number: AIBDSG_002

Start Date:

Sponsor Name: Medical University of Vienna (MUW)

Full Title: Sono-Response-Study A Pilot Study on the use of contrast enhanced ultrasound in Crohn’s disease

Medical condition: Inflammatory bowel disease (Crohn's disease)

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.1	10017947 - Gastrointestinal disorders	10011401	Crohn's disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2010-024094-39

Sponsor Protocol Number: Adip-2010

Start Date:

Sponsor Name: University of Ulm, University Hospital Ulm

Full Title: Offene, monozentrische, nicht kontrollierte und nicht randomisierte Phase IV-Studie zur Bestimmung der Pharmakokinetik von Carbapenemen in adipösen Patienten.

Medical condition: The purpose of this study is to determine the free tissue kinetics of ertapenem and meropenem in fatty tissue and intraperitoneal fluid up to 24 hours after administration of the IMP. Subjects are ...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2005-003023-40

Sponsor Protocol Number: 21805

Start Date:

Sponsor Name: Food Standards Agency

Full Title: The role of peanut specific T cell responses in children with peanut allergy and in children who are tolerant to peanuts

Medical condition: Children with Peanut Allergy

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2020-005019-29

Sponsor Protocol Number: Rux-cALL-Pol_2020

Start Date:

Sponsor Name: Medical University of Lodz

Full Title: Single-arm interventional study with ruxolitinib and AIOEP-BFM2017 chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway.

Medical condition: Acute Lymphoblastic Leukemia with confirmed activating of JAK/STAT pathway in children and adolescents

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.0	100000004864	10000845	Acute lymphoblastic leukemia	LLT
	22.0	100000004850	10072213	JAK-2 mutation	LLT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: PL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2007-000730-40

Sponsor Protocol Number: SOCRATES

Start Date:

Sponsor Name: Heinrich-Heine-Universität Düsseldorf

Full Title: Phase II study evaluating transarterial chemoembolization (TACE) in combination with sorafenib for the treatment of advanced hepatocellular carcinoma (HCC)

Medical condition: histologically proven advanced hepatocellular carcinoma (HCC) not suitable for resection or liver transplantation but without extrahepatic manifestations and without previous treatment for HCC

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10019828	Hepatocellular carcinoma non-resectable	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2009-011148-21

Sponsor Protocol Number: D0520C00012

Start Date:

Sponsor Name: AstraZeneca AB

Full Title: A 12-week, randomised, double-blind, placebo-controlled, parallel group, multinational, phase IIb dose range finding study to evaluate the efficacy and safety of AZD9668 administered orally at 3 do...

Medical condition: Chronic Obstructive Pulmonary Disease (COPD)

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10010952	COPD	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) SK (Completed)

Trial results: View results

Últimos ensayos

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas